Susanna Gatti High - Net Worth and Insider Trading
Susanna Gatti High Net Worth
The estimated net worth of Susanna Gatti High is at least $4 Million dollars as of 2024-11-29. Susanna Gatti High is the COO of Dyne Therapeutics Inc and owns about 131,636 shares of Dyne Therapeutics Inc (DYN) stock worth over $4 Million. Susanna Gatti High is also the COO of bluebird bio Inc and owns about 13,735 shares of bluebird bio Inc (BLUE) stock worth over $5,189. Details can be seen in Susanna Gatti High's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susanna Gatti High has not made any transactions after 2024-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susanna Gatti High
Susanna Gatti High Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susanna Gatti High owns 2 companies in total, including Dyne Therapeutics Inc (DYN) , and bluebird bio Inc (BLUE) .
Click here to see the complete history of Susanna Gatti High’s form 4 insider trades.
Insider Ownership Summary of Susanna Gatti High
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DYN | Dyne Therapeutics Inc | 2024-09-18 | Chief Operating Officer |
| BLUE | bluebird bio Inc | 2018-12-06 | Chief Operating Officer |
Susanna Gatti High Latest Holdings Summary
Susanna Gatti High currently owns a total of 2 stocks. Among these stocks, Susanna Gatti High owns 131,636 shares of Dyne Therapeutics Inc (DYN) as of September 18, 2024, with a value of $4 Million and a weighting of 99.87%. Susanna Gatti High also owns 13,735 shares of bluebird bio Inc (BLUE) as of December 6, 2018, with a value of $5,189 and a weighting of 0.13%.
Latest Holdings of Susanna Gatti High
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DYN | Dyne Therapeutics Inc | 2024-09-18 | 131,636 | 31.13 | 4,097,829 |
| BLUE | bluebird bio Inc | 2018-12-06 | 13,735 | 0.38 | 5,189 |
Holding Weightings of Susanna Gatti High
Susanna Gatti High Form 4 Trading Tracker
According to the SEC Form 4 filings, Susanna Gatti High has made a total of 18 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 8,976 shares on September 18, 2024, which brought Susanna Gatti High around $308,864.
According to the SEC Form 4 filings, Susanna Gatti High has made a total of 0 transactions in bluebird bio Inc (BLUE) over the past 5 years. The most-recent trade in bluebird bio Inc is the sale of 1,875 shares on December 6, 2018, which brought Susanna Gatti High around $198,206.
Insider Trading History of Susanna Gatti High
- 1
Susanna Gatti High Trading Performance
Susanna Gatti High Ownership Network
Susanna Gatti High Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Susanna Gatti High is the Chief Operating Officer of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , See Remarks Oxana Beskrovnaya , and director & 10 percent owner Dirk Kersten .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Susanna Gatti High made 15 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 273,683. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 466,177 shares made by Dirk Kersten , a net sale of 330,251 shares made by Richard William Scalzo , and a net sale of 143,354 shares made by Oxana Beskrovnaya .
In summary, during the past 3 months, insiders sold 548,479 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 516,479 shares. During the past 18 months, 8,028,019 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,281,734 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Susanna Gatti High Mailing Address
Above is the net worth, insider trading, and ownership report for Susanna Gatti High. You might contact Susanna Gatti High via mailing address: 75 Lorimer Road, Belmont Ma 02141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
